PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.22%
Positive revenue growth while MCHP is negative. John Neff might see a notable competitive edge here.
31.76%
Positive gross profit growth while MCHP is negative. John Neff would see a clear operational edge over the competitor.
80.61%
Positive EBIT growth while MCHP is negative. John Neff might see a substantial edge in operational management.
122.45%
Positive operating income growth while MCHP is negative. John Neff might view this as a competitive edge in operations.
106.92%
Positive net income growth while MCHP is negative. John Neff might see a big relative performance advantage.
104.76%
Positive EPS growth while MCHP is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
110.00%
Diluted EPS growth of 110.00% while MCHP is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-0.95%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.23%
Dividend growth above 1.5x MCHP's 0.13%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
49.73%
Positive OCF growth while MCHP is negative. John Neff would see this as a clear operational advantage vs. the competitor.
19.45%
Positive FCF growth while MCHP is negative. John Neff would see a strong competitive edge in net cash generation.
61.72%
10Y revenue/share CAGR at 50-75% of MCHP's 88.63%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
22.16%
5Y revenue/share CAGR similar to MCHP's 22.92%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-8.11%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
110.74%
Positive long-term OCF/share growth while MCHP is negative. John Neff would see a structural advantage in sustained cash generation.
22.04%
Positive OCF/share growth while MCHP is negative. John Neff might see a comparative advantage in operational cash viability.
138.85%
Positive 3Y OCF/share CAGR while MCHP is negative. John Neff might see a big short-term edge in operational efficiency.
79.23%
Below 50% of MCHP's 298.47%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
31.73%
Below 50% of MCHP's 101.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-8.03%
Negative 3Y CAGR while MCHP is 108.95%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
59.53%
Below 50% of MCHP's 183.99%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
0.89%
Positive 5Y equity/share CAGR while MCHP is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-5.83%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
460.05%
Dividend/share CAGR of 460.05% while MCHP is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
428.42%
Below 50% of MCHP's 1028.50%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
260.00%
3Y dividend/share CAGR above 1.5x MCHP's 112.45%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
15.35%
Our AR growth while MCHP is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.99%
Inventory growth well above MCHP's 7.63%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.41%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.42%
75-90% of MCHP's 3.90%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.98%
We expand SG&A while MCHP cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.